SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-003808
Filing Date
2022-02-24
Accepted
2022-02-24 16:00:07
Documents
85
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crdf-20211231.htm   iXBRL 10-K 1875087
2 EX-23.1 a231exq42021.htm EX-23.1 3213
3 EX-31.1 a311exq42021.htm EX-31.1 11906
4 EX-31.2 a312exq42021.htm EX-31.2 11918
5 EX-32.1 a321exq42021.htm EX-32.1 6163
6 EX-32.2 a322exq42021.htm EX-32.2 6194
  Complete submission text file 0001628280-22-003808.txt   8640402

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20211231.xsd EX-101.SCH 57184
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20211231_cal.xml EX-101.CAL 98422
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20211231_def.xml EX-101.DEF 325139
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20211231_lab.xml EX-101.LAB 726131
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20211231_pre.xml EX-101.PRE 492729
79 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20211231_htm.xml XML 1409336
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35558 | Film No.: 22670782
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences